MyFinsight
Home
Blog
About
Issuance of common stock,
net of issuance...
$140,201K
Proceeds from issuance of
common stock upon...
$6,250K
(-93.32%↓ Y/Y)
Issuance of common stock
from atm offering,...
$6,162K
(137.46%↑ Y/Y)
Proceeds from issuance of
common stock under...
$160K
(-18.78%↓ Y/Y)
Proceeds from issuance of
common stock in...
$34K
Net cash provided by
financing activities
$149,987K
(61.59%↑ Y/Y)
Canceled cashflow
$2,820K
Net increase
(decrease) in cash and cash...
$108,466K
(691.10%↑ Y/Y)
Canceled cashflow
$41,521K
Principal payments on
finance leases
$2,820K
(-20.65%↓ Y/Y)
Stock-based compensation
$5,499K
(-49.39%↓ Y/Y)
Non-cash finance lease
expense
$3,001K
(-38.55%↓ Y/Y)
Accrued and other
current liabilities
$2,597K
(25.64%↑ Y/Y)
Non-cash operating lease
expense
$984K
(-44.94%↓ Y/Y)
Depreciation
$371K
(-61.07%↓ Y/Y)
Accretion of operating
lease liabilities
$96K
(-68.93%↓ Y/Y)
Loss on foreign
currency exchange rates
$84K
(37.70%↑ Y/Y)
Accrued interest
payable under finance...
$20K
(-80.00%↓ Y/Y)
Net cash used in
operating activities
-$41,514K
(32.20%↑ Y/Y)
Effect of exchange rate
changes on cash and cash...
-$7K
(-118.42%↓ Y/Y)
Canceled cashflow
$12,652K
Net loss
-$51,018K
(37.07%↑ Y/Y)
Lease liabilities
-$1,057K
(50.00%↑ Y/Y)
Other assets
$934K
(346.89%↑ Y/Y)
Accounts payable
-$908K
(-141.54%↓ Y/Y)
Prepaid expenses and
other current assets
$249K
(-75.40%↓ Y/Y)
Back
Back
Cash Flow
Cabaletta Bio, Inc. (CABA)
Cabaletta Bio, Inc. (CABA)
source: myfinsight.com